Thomas Marron - Internal Medicine | Mount Sinai

Biography

Specialties

Internal Medicine, Cancer (Oncology)

Education

MD, Icahn School of Medicine at Mount Sinai

Residency, Internal Medicine, Mount Sinai Hospital and Medical Center

Fellowship, Medical Oncology, Mount Sinai Hospital and Medical Center

Certifications

American Board of Internal Medicine

Publications

77

Publications

Selected Publications

Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study. Kylie Fletcher, Alessio Cortellini, Teja Ganta, Roma Kankaria, Haocan Song, Fei Ye, Rebecca Irlmeier, Neha Debnath, Anwaar Saeed, Maluki Radford, Asrar Alahmadi, Akiva Diamond, Christopher Hoimes, Carolyn J. Presley, Dwight H. Owen, Sarah Abou Alaiwi, Amin H. Nassar, Giuseppe Lamberti, Fabiana Perrone, Sebastiano Buti, Raffaele Giusti, Marco Filetti, Vito Vanella, Domenico Mallardo, Tamara A. Sussman, Domenico Galetta, Foteini Kalofonou, Ella Daniels, Paolo A. Ascierto, David J. Pinato, Caroline Nebhan, Stephanie Berg, Toni K. Choueiri, Thomas U. Marron, Yinghong Wang, Abdul Rafeh Naqash, Douglas B. Johnson. Cancer Letters

Optimizing care in early phase cancer trials: The role of palliative care. Fionnuala Crowley, Richard Sheppard, Stephanie Lehrman, Eve Easton, Thomas U. Marron, Deborah Doroshow, Debora Afezolli. Cancer Treatment Reviews

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study. Amin H. Nassar, So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances Shepherd, Chao Xu, David Kaldas, Jhanelle E. Gray, Thomas J. Dilling, Joel W. Neal, Heather A. Wakelee, Yufei Liu, Steven H. Lin, Tariq Abuali, Arya Amini, Yunan Nie, Tejas Patil, Anastasiya Lobachov, Jair Bar, Bailey Fitzgerald, Yu Fujiwara, Thomas U. Marron, Rohit Thummalapalli, Helena Yu, Dwight H. Owen, John Sharp, Saira Farid, Pedro Rocha, Edurne Arriola, Angelica D'Aiello, Haiying Cheng, Ryan Whitaker, Kaushal Parikh, Yash Ashara, Luxi Chen, Kamya Sankar, Jeremy P. Harris, Misako Nagasaka, Adanma Ayanambakkam, Ana I. Velazquez, Meera Ragavan, Jessica J. Lin, Zofia Piotrowska, Molly Wilgucki, Joshua Reuss, Heike Luders, Christian Grohe, Javier Baena Espinar, Ella Feiner, Salman R. Punekar, Shruti Gupta, Ticiana Leal, David J. Kwiatkowski, Raymond H. Mak, Elio Adib, Abdul Rafeh Naqash, Sarah B. Goldberg. Journal of Thoracic Oncology

View All Publications

Video

Cancer Immunotherapy: In search of the other "c" word for our cancer patients (cure)

Office Locations

Annenberg Building Floor 24th floor Room BOX 1078

1468 Madison Ave

New York, NY 10029

212-241-0942

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Marron during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Regeneron Pharmaceuticals
Astellas Pharma Inc.
AstraZeneca AB
Genentech, Inc.
Merck & Co., Inc.
NGMbio
Glenmark
Ono Pharmaceuticals
Arcus
EMD Serono, Inc
AbbVie Biotherapeutics, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Marron during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Regeneron Pharmaceuticals
Astellas Pharma Inc.
AstraZeneca AB
Genentech, Inc.
Merck & Co., Inc.
NGMbio
Glenmark
Ono Pharmaceuticals
Arcus
EMD Serono, Inc
AbbVie Biotherapeutics, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.